Literature DB >> 2475526

Prevalence of pulmonary embolism at necropsy in patients with cancer.

E Svendsen1, B Karwinski.   

Abstract

The series studied comprised 6197 patients who had died of or who had cancer at death and represents all patients with cancer from 21,530 necropsies performed at this department from 1960-84. Pulmonary embolism was significantly more common among cancer patients than in those with non-neoplastic diseases. Among those palliatively treated, patients with ovarian cancer, cancer of the extrahepatic bile duct system, and cancer of the stomach had the highest prevalence of pulmonary embolism (34.6%, 31.7%, and 15.2%, respectively). Necropsy patients with cancer of the oesophagus and larynx, together with leukaemia, myelomatosis, and malignant lymphoma had the lowest prevalence (0-5.6%). Palliatively treated cancers in organs of the peritoneal cavity had a significantly higher incidence than all other cancers combined. Cancer of the peritoneal cavity may impede venous drainage from the lower limbs and thus be an important factor in the onset of deep calf vein thrombosis and pulmonary embolism. It is concluded that cancer represents an increased risk factor for onset of pulmonary embolism, in particular in patients with ovarian cancer and cancer of the extrahepatic bile duct system.

Entities:  

Mesh:

Year:  1989        PMID: 2475526      PMCID: PMC1142055          DOI: 10.1136/jcp.42.8.805

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Thrombophlebitis and cancer.

Authors:  J S LIEBERMAN; J BORRERO; E URDANETA; I S WRIGHT
Journal:  JAMA       Date:  1961-08-26       Impact factor: 56.272

Review 2.  Oral contraceptives, blood clotting and thrombosis.

Authors:  L Poller
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

3.  Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.

Authors:  J E Mason; V T DeVita; G P Canellos
Journal:  Blood       Date:  1974-10       Impact factor: 22.113

4.  Thrombocytosis in patients with lung cancer.

Authors:  S E Silvis; N Turkbas; A Doscherholmen
Journal:  JAMA       Date:  1970-03-16       Impact factor: 56.272

Review 5.  [Tumor, thrombocytosis and thrombosis risk].

Authors:  W Schneider
Journal:  Dtsch Med Wochenschr       Date:  1988-05-06       Impact factor: 0.628

6.  [Cause of death in cancer patients].

Authors:  H Berger; N Freudenberg
Journal:  Med Welt       Date:  1983-01-28

Review 7.  Thrombosis and cancer.

Authors:  H F Dvorak
Journal:  Hum Pathol       Date:  1987-03       Impact factor: 3.466

8.  Comparison of clinical and postmortem diagnosis of pulmonary embolism.

Authors:  B Karwinski; E Svendsen
Journal:  J Clin Pathol       Date:  1989-02       Impact factor: 3.411

9.  Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies.

Authors:  N C Sun; W M McAfee; G J Hum; J M Weiner
Journal:  Am J Clin Pathol       Date:  1979-01       Impact factor: 2.493

10.  Plasma level of estradiol in patients with ovarian malignant tumors.

Authors:  C G Mählck; T Bäckström; O Kjellgren
Journal:  Gynecol Oncol       Date:  1988-07       Impact factor: 5.482

View more
  15 in total

1.  Clinical analysis of endometrial cancer patients with obesity, diabetes, and hypertension.

Authors:  Xiang-Hua Yin; Hong-Yan Jia; Xiao-Rui Xue; Shi-Zhang Yang; Zhong-Qin Wang
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 2.  Prevention and Treatment of Cancer-Associated Venous Thromboembolism: a Review.

Authors:  Kristen M Sanfilippo; Tzu-Fei Wang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-20

Review 3.  Cancer-associated venous thromboembolism.

Authors:  Alok A Khorana; Nigel Mackman; Anna Falanga; Ingrid Pabinger; Simon Noble; Walter Ageno; Florian Moik; Agnes Y Y Lee
Journal:  Nat Rev Dis Primers       Date:  2022-02-17       Impact factor: 65.038

4.  Thrombotic complications following liver resection for colorectal metastases are preventable.

Authors:  G Morris-Stiff; A White; D Gomez; G Toogood; J P A Lodge; K R Prasad
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

5.  Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky business.

Authors:  F P Sarasin; M H Eckman
Journal:  J Gen Intern Med       Date:  1993-09       Impact factor: 5.128

6.  Efficacy and safety of enoxaparin for preventing venous thromboembolic events after laparoscopic colorectal cancer surgery: a randomized-controlled trial (YCOG 1404).

Authors:  Kazuya Nakagawa; Jun Watanabe; Mitsuyoshi Ota; Yusuke Suwa; Shinsuke Suzuki; Hirokazu Suwa; Masashi Momiyama; Atsushi Ishibe; Yusuke Saigusa; Takeharu Yamanaka; Chikara Kunisaki; Itaru Endo
Journal:  Surg Today       Date:  2019-08-05       Impact factor: 2.549

7.  Effect of ovarian tumor characteristics on venous thromboembolic risk.

Authors:  Arvind Bakhru
Journal:  J Gynecol Oncol       Date:  2013-01-08       Impact factor: 4.401

8.  The clinical characteristics of pulmonary embolism in patients with malignancy: a single medical institutional experience.

Authors:  Asha Karippot; Hamid S Shaaban; Michael Maroules; Gunwant Guron
Journal:  N Am J Med Sci       Date:  2012-11

9.  Impact of cancer on the effectiveness of cardiac Troponin I to predict right ventricular dysfunction in acute pulmonary embolism.

Authors:  Karsten Keller; Martin Geyer; Johannes Beule; Meike Coldewey; Jörn Oliver Balzer; Wolfgang Dippold
Journal:  Thorac Cancer       Date:  2015-01-22       Impact factor: 3.500

10.  Cancer-associated thrombosis: clinical presentation and survival.

Authors:  Magid H Amer
Journal:  Cancer Manag Res       Date:  2013-07-26       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.